{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:45:43Z","timestamp":1787240743819,"version":"build-2736575974"},"reference-count":26,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170825"],"award-info":[{"award-number":["82170825"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100833"],"award-info":[{"award-number":["82100833"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U21A20355"],"award-info":[{"award-number":["U21A20355"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chongqing medical scientific research project"},{"name":"Joint project of Chongqing Health Commission and Science and Technology Bureau","award":["2023MSXM002"],"award-info":[{"award-number":["2023MSXM002"]}]},{"name":"Joint Medical Research Project of Chongqing Science and Technology Commission & Chongqing Health and Family Planning Commission","award":["2022ZDXM003"],"award-info":[{"award-number":["2022ZDXM003"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>68Ga-Pentixafor positron emission tomography\/computed tomography (PET\/CT) is an emerging method for the classification diagnosis primary aldosteronism (PA). However, the diagnosis criteria are still controversial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compare the accuracy of different criteria of 68Ga-Pentixafor PET\/CT in the classification diagnosis of PA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a retrospective study at a tertiary hospital in China. Patients with PA who had undergone PET\/CT and had classification diagnosis of unilateral PA (UPA) or bilateral PA (BPA) based on surgery or adrenal venous sampling were included. Area under the receiver operating characteristic curve (AUC), specificity, and sensitivity were used to analyze the accuracy of the lateralization index (LI) based on adrenal maximum standardized uptake value (SUVmax), dominant side SUVmax adjusted by liver, dominant side of SUVmax, and visual analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 208 patients with PA (including 128 UPA and 80 BPA) were analyzed. The AUCs for diagnosing UPA using LI and visual analysis were both 0.82, higher than that of the dominant side of SUVmax (0.72) and dominant side SUVmax adjusted by liver (0.71). Visual analysis showed a sensitivity of 0.73 and a specificity of 0.88. The LI cutoff of 1.50 resulted in the highest Youden index of 0.59, with a sensitivity of 0.68 and a specificity of 0.91. When the LI cutoff was increased to 1.65, the sensitivity reduced to 0.61, while the specificity increased to 0.96.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Both LI and visual analysis could be used for interpretation the results of 68Ga-Pentixafor PET\/CT; nevertheless, visual analysis is more sensitive, and LI is more advantageous in specificity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgae747","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T07:21:36Z","timestamp":1732778496000},"page":"e2583-e2590","source":"Crossref","is-referenced-by-count":17,"title":["Comparison of Different Diagnostic Criteria of 68Ga-Pentixafor PET\/CT for the Classification of Primary Aldosteronism"],"prefix":"10.1210","volume":"110","author":[{"given":"Xiangshuang","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University , Chongqing 400016 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University , Chongqing 400016 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University , Chongqing 400016 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2925-0583","authenticated-orcid":false,"given":"Jinbo","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University , Chongqing 400016 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University , Chongqing 400016 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aipin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Graduate Administration Office, The First Affiliated Hospital of Chongqing Medical University , Chongqing 400016 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"He","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University , Chongqing 400016 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengping","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University , Chongqing 400016 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University , Chongqing 400016 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6601-3208","authenticated-orcid":false,"given":"Hua","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University , Chongqing 400016 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7249-6445","authenticated-orcid":false,"given":"Qifu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University , Chongqing 400016 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0238-4779","authenticated-orcid":false,"given":"Shumin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University , Chongqing 400016 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Chongqing Primary Aldosteronism Study (CONPASS) Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suxin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangla","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,11,29]]},"reference":[{"issue":"14","key":"2025071507121998100_dgae747-B1","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"2025071507121998100_dgae747-B2","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"2025071507121998100_dgae747-B3","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","article-title":"Primary aldosteronism in patients in China with recently detected hypertension","volume":"75","author":"Xu","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2025071507121998100_dgae747-B4","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025071507121998100_dgae747-B5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","article-title":"Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism","volume":"151","author":"Kempers","year":"2009","journal-title":"Ann Intern Med"},{"issue":"6","key":"2025071507121998100_dgae747-B6","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1210\/jc.2018-02089","article-title":"Discordance between imaging and adrenal vein sampling in primary aldosteronism irrespective of interpretation criteria","volume":"104","author":"Sam","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025071507121998100_dgae747-B7","doi-asserted-by":"crossref","first-page":"e2255609","DOI":"10.1001\/jamanetworkopen.2022.55609","article-title":"Accuracy of gallium-68 pentixafor positron emission tomography-computed tomography for subtyping diagnosis of primary aldosteronism","volume":"6","author":"Hu","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2025071507121998100_dgae747-B8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/clinem\/dgad421","article-title":"The value of targeting CXCR4 with 68Ga-Pentixafor PET\/CT for subtyping primary aldosteronism","volume":"109","author":"Zheng","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2025071507121998100_dgae747-B9","doi-asserted-by":"crossref","first-page":"1291775","DOI":"10.3389\/fendo.2024.1291775","article-title":"A comparison of the performance of (68)Ga-Pentixafor PET\/CT versus adrenal vein sampling for subtype diagnosis in primary aldosteronism","volume":"15","author":"Yin","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2025071507121998100_dgae747-B10","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s00330-022-09058-x","article-title":"Functional nodules in primary aldosteronism: identification of CXCR4 expression with (68)Ga-Pentixafor PET\/CT","volume":"33","author":"Gao","year":"2023","journal-title":"Eur Radiol"},{"issue":"1","key":"2025071507121998100_dgae747-B11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2967\/jnumed.123.266061","article-title":"Clinical value of (68)Ga-Pentixafor PET\/CT in subtype diagnosis of primary aldosteronism patients with adrenal micronodules","volume":"65","author":"Ding","year":"2024","journal-title":"J Nucl Med"},{"issue":"11","key":"2025071507121998100_dgae747-B12","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1007\/s00259-020-04722-0","article-title":"Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism","volume":"47","author":"Ding","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"2025071507121998100_dgae747-B13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","article-title":"Targeting CXCR4 (CXC Chemokine Receptor Type 4) for molecular imaging of aldosterone-producing adenoma","volume":"71","author":"Heinze","year":"2018","journal-title":"Hypertension"},{"issue":"2","key":"2025071507121998100_dgae747-B14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ando.2022.02.001","article-title":"Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) on diagnosis of Cushing's syndrome","volume":"83","author":"Tabarin","year":"2022","journal-title":"Ann Endocrinol (Paris)"},{"issue":"10","key":"2025071507121998100_dgae747-B15","doi-asserted-by":"crossref","first-page":"e2338209","DOI":"10.1001\/jamanetworkopen.2023.38209","article-title":"Corticotropin stimulation in adrenal venous sampling for patients with primary aldosteronism: the ADOPA randomized clinical trial","volume":"6","author":"Yang","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2025071507121998100_dgae747-B16","doi-asserted-by":"crossref","first-page":"8647026","DOI":"10.1155\/2018\/8647026","article-title":"Age-related cutoffs of plasma aldosterone\/renin concentration for primary aldosteronism screening","volume":"2018","author":"Ma","year":"2018","journal-title":"Int J Endocrinol"},{"issue":"7","key":"2025071507121998100_dgae747-B17","doi-asserted-by":"crossref","first-page":"dgaa282","DOI":"10.1210\/clinem\/dgaa282","article-title":"Development and validation of criteria for sparing confirmatory tests in diagnosing primary aldosteronism","volume":"105","author":"Wang","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025071507121998100_dgae747-B18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/HYPERTENSIONAHA.117.10197","article-title":"Confirmatory tests for the diagnosis of primary aldosteronism: a prospective diagnostic accuracy study","volume":"71","author":"Song","year":"2018","journal-title":"Hypertension"},{"issue":"3","key":"2025071507121998100_dgae747-B19","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.1210\/clinem\/dgz150","article-title":"Diagnosis of primary aldosteronism by seated saline suppression test-variability between immunoassay and HPLC-MS\/MS","volume":"105","author":"Thuzar","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025071507121998100_dgae747-B20","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMcp065470","article-title":"Clinical practice. The incidentally discovered adrenal mass","volume":"356","author":"Young","year":"2007","journal-title":"N Engl J Med"},{"issue":"7","key":"2025071507121998100_dgae747-B21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0009-9260(05)81739-8","article-title":"The size of normal adrenal glands on computed tomography","volume":"49","author":"Vincent","year":"1994","journal-title":"Clin Radiol"},{"issue":"1","key":"2025071507121998100_dgae747-B22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jamcollsurg.2019.03.012","article-title":"Influence of adrenal venous sampling on management in patients with primary aldosteronism independent of lateralization on cross-sectional imaging","volume":"229","author":"Campbell","year":"2019","journal-title":"J Am Coll Surg"},{"issue":"4","key":"2025071507121998100_dgae747-B23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S2213-8587(14)70069-5","article-title":"Adrenal vein sampling in primary aldosteronism: towards a standardised protocol","volume":"3","author":"Monticone","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2025071507121998100_dgae747-B24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","article-title":"An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism","volume":"63","author":"Rossi","year":"2014","journal-title":"Hypertension"},{"issue":"9","key":"2025071507121998100_dgae747-B25","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025071507121998100_dgae747-B26","doi-asserted-by":"crossref","unstructured":"Zhang X, Song Y, Jing Y, et al \u00a02024. Data from: Supplement of Comparison of Different Diagnostic Criteria of 68Ga-Pentixafor PET\/CT for the Classification of Primary Aldosteronism. Figshare. doi:10.6084\/m9.figshare.27108916.v1. Date of deposit 26 September 2024.","DOI":"10.1101\/2024.07.26.24311092"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae747\/60922136\/dgae747.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/8\/e2583\/60922136\/dgae747.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/8\/e2583\/60922136\/dgae747.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T11:12:33Z","timestamp":1752577953000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/8\/e2583\/7913982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":26,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,11,29]]},"published-print":{"date-parts":[[2025,7,15]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae747","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2024,11,29]]}}}